SCHEMBL5840840

SCHEMBL5840840

CCn1cnc2c(Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)nc(NC3CCCCC3N)nc21

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 14/20 0.84
CLK1 P49759 8/20 0.70
CLK2 P49760 8/20 0.70
CLK4 Q9HAZ1 7/20 0.70
CCNB1 P14635 4/20 0.70
PRKCA P17252 2/20 0.70
NPC1 O15118 1/20 0.70
CCNT1 O60563 1/20 0.70
EGFR P00533 1/20 0.70
CDK4 P11802 1/20 0.70
EIF2AK2 P19525 1/20 0.70
CCNA2 P20248 1/20 0.70
CCND1 P24385 1/20 0.70
CCNE1 P24864 1/20 0.70
CDK2 P24941 1/20 0.70
CCND3 P30281 1/20 0.70
MTOR P42345 1/20 0.70
CDK7 P50613 1/20 0.70
CDK9 P50750 1/20 0.70
RAB9A P51151 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5840836 1.00 CDK1 (0.84) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5839171 0.91 CDK1 (1.00) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5839165 0.91 CDK1 (1.00) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5840325 0.91 CDK1 (0.83) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5840320 0.91 CDK1 (0.83) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5839495 0.85 CDK1 (0.83) CDK1PRKCACCNE1CDK2
SCHEMBL7203660 0.85 CDK1 (1.00) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5840461 0.85 CDK1 (0.83) CDK1PRKCACCNE1CDK2
SCHEMBL7203668 0.85 CDK1 (1.00) CDK1CLK1CLK2CLK4CCNB1
SCHEMBL5839489 0.85 CDK1 (0.83) CDK1PRKCACCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091346-B1 Purine derivatives and processes for their preparation NOVARTIS AG (CH) 2006-08-15 US disclosed
EP-0874846-B1 PURINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 2003-04-02 EP disclosed